Enovis Corporation (ENOV) — Fair Value Analysis

Base-case fair value (P50): $28.39 · Current price: $22.50 · Verdict: Undervalued

The Verdict on ENOV

Our Monte Carlo simulations indicate that ENOVIS CORP (ENOV) is Fairly Valued at its current price of $22.50. Despite trading at $22.50, the median fair value (P50) derived from thousands of forward-looking scenarios stands at $28.39. This suggests a potential +26.2% from the current level, positioning ENOV within a reasonable range of its intrinsic value based on our comprehensive model. Investors seeking substantial undervaluation may find the current pricing of ENOV reflective of its fundamentals, rather than a significant bargain or premium.

How ENOV stacks up against peers

ENOV’s operational and financial health is currently assessed as "average" relative to its sector peers. This average quality tier supports the Fairly Valued verdict, indicating that ENOV is not exhibiting extreme financial distress or exceptional outperformance that would significantly skew its fair value estimate away from its current trading price of $22.50. While an average quality tier suggests a stable foundation, it also implies that any substantial deviation from the $28.39 fair value might require a significant shift in its underlying business performance or sector dynamics.

What this means for investors

For investors, the Fairly Valued assessment means ENOV’s current price of $22.50 largely aligns with its intrinsic worth, with the simulations suggesting a +26.2% to the $28.39 fair value of $28.39. While this upside is noted, the overall verdict points to a balanced risk/reward profile at current levels, rather than a deep value opportunity. To understand the full distribution of potential outcomes, including the P10 bear case and P90 bull case targets, and to track ENOV's fair value as new fundamentals are released, sign up for a free FairCurve account.